Age-specific baseline characteristics of the study population according to coronary artery calcium score category
Characteristics . | Overall . | CACS category . | P for trend . | |||
---|---|---|---|---|---|---|
0 . | >0–100 . | 101–300 . | >300 . | |||
Age <45 years, n | n = 117 728 | n = 109 917 | n = 7155 | n = 522 | n = 134 | |
Age (years)a | 37.3 (4.6) | 37.1 (4.6) | 39.7 (3.8) | 40.8 (3.1) | 40.8 (3.0) | <0.001 |
Male (%) | 76.7 | 75.4 | 94.5 | 97.7 | 98.5 | <0.001 |
Alcohol intake (%)b | 24.7 | 24.1 | 33.1 | 37.0 | 37.8 | <0.001 |
Regular exercise (%)c | 12.8 | 12.7 | 14.1 | 16.7 | 16.9 | <0.001 |
Lipid-lowering drugs (%) | 2.2 | 1.8 | 6.5 | 12.5 | 21.8 | <0.001 |
Traditional risk factors | ||||||
Current smoking (%) | 22.3 | 21.5 | 33.3 | 38.6 | 42.8 | <0.001 |
Diabetes (%) | 3.3 | 2.8 | 9.0 | 12.5 | 23.9 | <0.001 |
Hypertension (%) | 11.5 | 10.4 | 25.7 | 41.8 | 50.0 | <0.001 |
Dyslipidaemia (%) | 41.5 | 40.1 | 61.7 | 63.2 | 67.9 | <0.001 |
Family history of CHD (%) | 6.2 | 6.1 | 8.5 | 9.2 | 11.3 | <0.001 |
Number of risk factors | <0.001 | |||||
0 | 41.2 | 42.9 | 18.5 | 13.1 | 7.6 | |
1 | 37.4 | 37.4 | 39.3 | 34.1 | 26.7 | |
2 | 17.1 | 16.1 | 29.9 | 32.7 | 38.9 | |
≥3 | 4.3 | 3.6 | 12.4 | 20.2 | 26.7 | |
Framingham risk score, % | ||||||
<10 | 96.4 | 97.1 | 87.4 | 79.1 | 70.2 | |
10–19 | 3.4 | 2.7 | 11.5 | 17.8 | 26.0 | |
≥20 | 0.2 | 0.2 | 1.0 | 3.1 | 3.8 | |
Age ≥45 years, n | n = 43 093 | n = 29 736 | n = 9 932 | n = 2 126 | n = 1 299 | |
Age (years)a | 52.7 (7.0) | 51.3 (5.9) | 54.7 (7.6) | 58.1 (8.5) | 61.7 (8.6) | <0.001 |
Male (%) | 67.7 | 61.6 | 80.5 | 82.7 | 85.5 | <0.001 |
Alcohol intake (%)b | 29.0 | 26.1 | 34.7 | 36.8 | 39.3 | <0.001 |
Regular exercise (%)c | 17.7 | 16.8 | 18.9 | 21.2 | 23.4 | <0.001 |
Lipid-lowering drugs (%) | 10.6 | 7.6 | 14.9 | 21.8 | 27.2 | <0.001 |
Traditional risk factors | ||||||
Current smoking (%) | 22.8 | 21.0 | 27.1 | 27.9 | 23.6 | <0.001 |
Diabetes (%) | 12.6 | 8.7 | 18.1 | 27.3 | 35.1 | <0.001 |
Hypertension (%) | 28.6 | 21.3 | 40.5 | 52.8 | 65.6 | <0.001 |
Dyslipidaemia (%) | 46.4 | 43.7 | 53.3 | 51.3 | 48.7 | <0.001 |
Family history of CHD (%) | 8.0 | 7.7 | 8.8 | 8.2 | 8.0 | 0.028 |
Number of risk factors | <0.001 | |||||
0 | 27.6 | 33.4 | 16.2 | 11.9 | 8.9 | |
1 | 37.9 | 38.6 | 37.5 | 32.9 | 30.8 | |
2 | 24.4 | 20.9 | 31.1 | 34.6 | 35.9 | |
≥3 | 10.1 | 7.1 | 15.2 | 20.6 | 24.4 | |
Framingham risk score, % | ||||||
<10 | 65.4 | 75.0 | 49.3 | 34.0 | 22.2 | |
10–19 | 25.6 | 20.4 | 36.2 | 40.4 | 40.1 | |
≥20 | 9.0 | 4.7 | 14.5 | 25.7 | 37.8 |
Characteristics . | Overall . | CACS category . | P for trend . | |||
---|---|---|---|---|---|---|
0 . | >0–100 . | 101–300 . | >300 . | |||
Age <45 years, n | n = 117 728 | n = 109 917 | n = 7155 | n = 522 | n = 134 | |
Age (years)a | 37.3 (4.6) | 37.1 (4.6) | 39.7 (3.8) | 40.8 (3.1) | 40.8 (3.0) | <0.001 |
Male (%) | 76.7 | 75.4 | 94.5 | 97.7 | 98.5 | <0.001 |
Alcohol intake (%)b | 24.7 | 24.1 | 33.1 | 37.0 | 37.8 | <0.001 |
Regular exercise (%)c | 12.8 | 12.7 | 14.1 | 16.7 | 16.9 | <0.001 |
Lipid-lowering drugs (%) | 2.2 | 1.8 | 6.5 | 12.5 | 21.8 | <0.001 |
Traditional risk factors | ||||||
Current smoking (%) | 22.3 | 21.5 | 33.3 | 38.6 | 42.8 | <0.001 |
Diabetes (%) | 3.3 | 2.8 | 9.0 | 12.5 | 23.9 | <0.001 |
Hypertension (%) | 11.5 | 10.4 | 25.7 | 41.8 | 50.0 | <0.001 |
Dyslipidaemia (%) | 41.5 | 40.1 | 61.7 | 63.2 | 67.9 | <0.001 |
Family history of CHD (%) | 6.2 | 6.1 | 8.5 | 9.2 | 11.3 | <0.001 |
Number of risk factors | <0.001 | |||||
0 | 41.2 | 42.9 | 18.5 | 13.1 | 7.6 | |
1 | 37.4 | 37.4 | 39.3 | 34.1 | 26.7 | |
2 | 17.1 | 16.1 | 29.9 | 32.7 | 38.9 | |
≥3 | 4.3 | 3.6 | 12.4 | 20.2 | 26.7 | |
Framingham risk score, % | ||||||
<10 | 96.4 | 97.1 | 87.4 | 79.1 | 70.2 | |
10–19 | 3.4 | 2.7 | 11.5 | 17.8 | 26.0 | |
≥20 | 0.2 | 0.2 | 1.0 | 3.1 | 3.8 | |
Age ≥45 years, n | n = 43 093 | n = 29 736 | n = 9 932 | n = 2 126 | n = 1 299 | |
Age (years)a | 52.7 (7.0) | 51.3 (5.9) | 54.7 (7.6) | 58.1 (8.5) | 61.7 (8.6) | <0.001 |
Male (%) | 67.7 | 61.6 | 80.5 | 82.7 | 85.5 | <0.001 |
Alcohol intake (%)b | 29.0 | 26.1 | 34.7 | 36.8 | 39.3 | <0.001 |
Regular exercise (%)c | 17.7 | 16.8 | 18.9 | 21.2 | 23.4 | <0.001 |
Lipid-lowering drugs (%) | 10.6 | 7.6 | 14.9 | 21.8 | 27.2 | <0.001 |
Traditional risk factors | ||||||
Current smoking (%) | 22.8 | 21.0 | 27.1 | 27.9 | 23.6 | <0.001 |
Diabetes (%) | 12.6 | 8.7 | 18.1 | 27.3 | 35.1 | <0.001 |
Hypertension (%) | 28.6 | 21.3 | 40.5 | 52.8 | 65.6 | <0.001 |
Dyslipidaemia (%) | 46.4 | 43.7 | 53.3 | 51.3 | 48.7 | <0.001 |
Family history of CHD (%) | 8.0 | 7.7 | 8.8 | 8.2 | 8.0 | 0.028 |
Number of risk factors | <0.001 | |||||
0 | 27.6 | 33.4 | 16.2 | 11.9 | 8.9 | |
1 | 37.9 | 38.6 | 37.5 | 32.9 | 30.8 | |
2 | 24.4 | 20.9 | 31.1 | 34.6 | 35.9 | |
≥3 | 10.1 | 7.1 | 15.2 | 20.6 | 24.4 | |
Framingham risk score, % | ||||||
<10 | 65.4 | 75.0 | 49.3 | 34.0 | 22.2 | |
10–19 | 25.6 | 20.4 | 36.2 | 40.4 | 40.1 | |
≥20 | 9.0 | 4.7 | 14.5 | 25.7 | 37.8 |
Age-specific baseline characteristics of the study population according to coronary artery calcium score category
Characteristics . | Overall . | CACS category . | P for trend . | |||
---|---|---|---|---|---|---|
0 . | >0–100 . | 101–300 . | >300 . | |||
Age <45 years, n | n = 117 728 | n = 109 917 | n = 7155 | n = 522 | n = 134 | |
Age (years)a | 37.3 (4.6) | 37.1 (4.6) | 39.7 (3.8) | 40.8 (3.1) | 40.8 (3.0) | <0.001 |
Male (%) | 76.7 | 75.4 | 94.5 | 97.7 | 98.5 | <0.001 |
Alcohol intake (%)b | 24.7 | 24.1 | 33.1 | 37.0 | 37.8 | <0.001 |
Regular exercise (%)c | 12.8 | 12.7 | 14.1 | 16.7 | 16.9 | <0.001 |
Lipid-lowering drugs (%) | 2.2 | 1.8 | 6.5 | 12.5 | 21.8 | <0.001 |
Traditional risk factors | ||||||
Current smoking (%) | 22.3 | 21.5 | 33.3 | 38.6 | 42.8 | <0.001 |
Diabetes (%) | 3.3 | 2.8 | 9.0 | 12.5 | 23.9 | <0.001 |
Hypertension (%) | 11.5 | 10.4 | 25.7 | 41.8 | 50.0 | <0.001 |
Dyslipidaemia (%) | 41.5 | 40.1 | 61.7 | 63.2 | 67.9 | <0.001 |
Family history of CHD (%) | 6.2 | 6.1 | 8.5 | 9.2 | 11.3 | <0.001 |
Number of risk factors | <0.001 | |||||
0 | 41.2 | 42.9 | 18.5 | 13.1 | 7.6 | |
1 | 37.4 | 37.4 | 39.3 | 34.1 | 26.7 | |
2 | 17.1 | 16.1 | 29.9 | 32.7 | 38.9 | |
≥3 | 4.3 | 3.6 | 12.4 | 20.2 | 26.7 | |
Framingham risk score, % | ||||||
<10 | 96.4 | 97.1 | 87.4 | 79.1 | 70.2 | |
10–19 | 3.4 | 2.7 | 11.5 | 17.8 | 26.0 | |
≥20 | 0.2 | 0.2 | 1.0 | 3.1 | 3.8 | |
Age ≥45 years, n | n = 43 093 | n = 29 736 | n = 9 932 | n = 2 126 | n = 1 299 | |
Age (years)a | 52.7 (7.0) | 51.3 (5.9) | 54.7 (7.6) | 58.1 (8.5) | 61.7 (8.6) | <0.001 |
Male (%) | 67.7 | 61.6 | 80.5 | 82.7 | 85.5 | <0.001 |
Alcohol intake (%)b | 29.0 | 26.1 | 34.7 | 36.8 | 39.3 | <0.001 |
Regular exercise (%)c | 17.7 | 16.8 | 18.9 | 21.2 | 23.4 | <0.001 |
Lipid-lowering drugs (%) | 10.6 | 7.6 | 14.9 | 21.8 | 27.2 | <0.001 |
Traditional risk factors | ||||||
Current smoking (%) | 22.8 | 21.0 | 27.1 | 27.9 | 23.6 | <0.001 |
Diabetes (%) | 12.6 | 8.7 | 18.1 | 27.3 | 35.1 | <0.001 |
Hypertension (%) | 28.6 | 21.3 | 40.5 | 52.8 | 65.6 | <0.001 |
Dyslipidaemia (%) | 46.4 | 43.7 | 53.3 | 51.3 | 48.7 | <0.001 |
Family history of CHD (%) | 8.0 | 7.7 | 8.8 | 8.2 | 8.0 | 0.028 |
Number of risk factors | <0.001 | |||||
0 | 27.6 | 33.4 | 16.2 | 11.9 | 8.9 | |
1 | 37.9 | 38.6 | 37.5 | 32.9 | 30.8 | |
2 | 24.4 | 20.9 | 31.1 | 34.6 | 35.9 | |
≥3 | 10.1 | 7.1 | 15.2 | 20.6 | 24.4 | |
Framingham risk score, % | ||||||
<10 | 65.4 | 75.0 | 49.3 | 34.0 | 22.2 | |
10–19 | 25.6 | 20.4 | 36.2 | 40.4 | 40.1 | |
≥20 | 9.0 | 4.7 | 14.5 | 25.7 | 37.8 |
Characteristics . | Overall . | CACS category . | P for trend . | |||
---|---|---|---|---|---|---|
0 . | >0–100 . | 101–300 . | >300 . | |||
Age <45 years, n | n = 117 728 | n = 109 917 | n = 7155 | n = 522 | n = 134 | |
Age (years)a | 37.3 (4.6) | 37.1 (4.6) | 39.7 (3.8) | 40.8 (3.1) | 40.8 (3.0) | <0.001 |
Male (%) | 76.7 | 75.4 | 94.5 | 97.7 | 98.5 | <0.001 |
Alcohol intake (%)b | 24.7 | 24.1 | 33.1 | 37.0 | 37.8 | <0.001 |
Regular exercise (%)c | 12.8 | 12.7 | 14.1 | 16.7 | 16.9 | <0.001 |
Lipid-lowering drugs (%) | 2.2 | 1.8 | 6.5 | 12.5 | 21.8 | <0.001 |
Traditional risk factors | ||||||
Current smoking (%) | 22.3 | 21.5 | 33.3 | 38.6 | 42.8 | <0.001 |
Diabetes (%) | 3.3 | 2.8 | 9.0 | 12.5 | 23.9 | <0.001 |
Hypertension (%) | 11.5 | 10.4 | 25.7 | 41.8 | 50.0 | <0.001 |
Dyslipidaemia (%) | 41.5 | 40.1 | 61.7 | 63.2 | 67.9 | <0.001 |
Family history of CHD (%) | 6.2 | 6.1 | 8.5 | 9.2 | 11.3 | <0.001 |
Number of risk factors | <0.001 | |||||
0 | 41.2 | 42.9 | 18.5 | 13.1 | 7.6 | |
1 | 37.4 | 37.4 | 39.3 | 34.1 | 26.7 | |
2 | 17.1 | 16.1 | 29.9 | 32.7 | 38.9 | |
≥3 | 4.3 | 3.6 | 12.4 | 20.2 | 26.7 | |
Framingham risk score, % | ||||||
<10 | 96.4 | 97.1 | 87.4 | 79.1 | 70.2 | |
10–19 | 3.4 | 2.7 | 11.5 | 17.8 | 26.0 | |
≥20 | 0.2 | 0.2 | 1.0 | 3.1 | 3.8 | |
Age ≥45 years, n | n = 43 093 | n = 29 736 | n = 9 932 | n = 2 126 | n = 1 299 | |
Age (years)a | 52.7 (7.0) | 51.3 (5.9) | 54.7 (7.6) | 58.1 (8.5) | 61.7 (8.6) | <0.001 |
Male (%) | 67.7 | 61.6 | 80.5 | 82.7 | 85.5 | <0.001 |
Alcohol intake (%)b | 29.0 | 26.1 | 34.7 | 36.8 | 39.3 | <0.001 |
Regular exercise (%)c | 17.7 | 16.8 | 18.9 | 21.2 | 23.4 | <0.001 |
Lipid-lowering drugs (%) | 10.6 | 7.6 | 14.9 | 21.8 | 27.2 | <0.001 |
Traditional risk factors | ||||||
Current smoking (%) | 22.8 | 21.0 | 27.1 | 27.9 | 23.6 | <0.001 |
Diabetes (%) | 12.6 | 8.7 | 18.1 | 27.3 | 35.1 | <0.001 |
Hypertension (%) | 28.6 | 21.3 | 40.5 | 52.8 | 65.6 | <0.001 |
Dyslipidaemia (%) | 46.4 | 43.7 | 53.3 | 51.3 | 48.7 | <0.001 |
Family history of CHD (%) | 8.0 | 7.7 | 8.8 | 8.2 | 8.0 | 0.028 |
Number of risk factors | <0.001 | |||||
0 | 27.6 | 33.4 | 16.2 | 11.9 | 8.9 | |
1 | 37.9 | 38.6 | 37.5 | 32.9 | 30.8 | |
2 | 24.4 | 20.9 | 31.1 | 34.6 | 35.9 | |
≥3 | 10.1 | 7.1 | 15.2 | 20.6 | 24.4 | |
Framingham risk score, % | ||||||
<10 | 65.4 | 75.0 | 49.3 | 34.0 | 22.2 | |
10–19 | 25.6 | 20.4 | 36.2 | 40.4 | 40.1 | |
≥20 | 9.0 | 4.7 | 14.5 | 25.7 | 37.8 |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.